From: Systematic review of the use of translated patient-reported outcome measures in cancer trials
Reference | Number of sites and (number of countries) examples of recruiting countries | PRO endpoint | PROM data collected | Number of translated versions of PROM available and examples | Use of translated PROM reported |
---|---|---|---|---|---|
Armstrong et al. [19] | 17 (3) USA, Canada, and UK | Secondary | FKSI-15a | 35 (Hindi, Chinese, Arabic, Thai) | No |
Yao et al. [20] | 97 (25) Europe, Japan, South Korea | Secondary | FACT-Gb | 71 (Italian, Japanese, Korean) | No |
Schöffski et al., primary paper [21] Hudgens et al., quality of life paper [22] | 110 (22) USA, Western Europe, Asia, Eastern Europe | Exploratory | QLQ C-30a EQ-5Da | 93 (Spanish, Hindi, Mandarin) 180 (Spanish, Thai, Malaysian) | No |
O’Shaughnessy et al. [23] | Approximately 65 North America, Europe, and Asia | Secondary | EORTC-C30b EQ-5D-5Lb BPI-SFb | 99 (Bengali, Malay, Mandarin) 170 (Spanish, Serbian, Simplified Chinese) 52 (Simplified Chinese, Malay, French) | No |
Senan et al. [24] | 125 (21) NS | Secondary | Swallowing diaryb | Not known | No |
Ryan et al. [25] | 113 (19) NS | Secondary | EORTC QLQ-C30b EQ-5Db | 99 (Bengali, Malay, Mandarin) 180 (Spanish, Thai, Malaysian) | No |
Verma et al., primary paper [26] Welslau et al., secondary paper [27] | 213 (26)Â Uk, South Korea, Germany | Secondary Exploratory | DASa [27]a | 56 (Urdu, Afrikaans, Hindi) (not known) | Consent form and other written information translated (when applicable)b |
Escudier et al. [28] | Multi-centre, (NS) | Secondary Exploratory | FACIT-Fatiguea EQ-5Da SQLQa Bespoke questionnaire adapted from OMDQ | 64 (Vietnamese, Punjabi, Chinese) 180 (Spanish, Thai, Malaysian) Not known Not known | No |